Heron Therapeutics (HRTX) vs XBiotech (XBIT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
XBiotech (XBIT) has outperformed Heron Therapeutics (HRTX) over the past year, losing 18.2% versus a loss of 73.5%. Over five years, XBIT leads with a -83.3% price change compared with -96.6% for HRTX. Heron Therapeutics is the larger company by market cap ($68.0 million vs $67.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HRTX | XBIT |
|---|---|---|
| Share price | $0.3582 | $2.20 |
| Market cap | $68.01M | $67.07M |
| 1-day change | -6.79% | +0.46% |
| YTD return | -72.45% | -7.95% |
| 1-year return | -73.47% | -18.22% |
| 5-year return | -96.62% | -83.35% |
| Forward P/E | — | 16.92 |
| EPS (TTM) | $-0.18 | $-1.48 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.58 | $3.44 |
| 52-week low | $0.26 | $2.09 |
| Distance from 52-week high | -77.33% | -36.05% |
| Analyst consensus | none | — |
| Avg. price target upside | +1854.22% | — |
| Average volume | 2.59M | 40.47K |
| Shares outstanding | 189.85M | 30.49M |
| Employees | 128 | 87 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- XBIT has outperformed HRTX by 55.3 percentage points over the past year.
About Heron Therapeutics
HRTX stock →Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.
Healthcare · Biotechnology · 128 employees
About XBiotech
XBIT stock →XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.
Healthcare · Biotechnology · 87 employees
HRTX vs XBIT FAQ
Which is bigger, Heron Therapeutics or XBiotech?
Heron Therapeutics (HRTX) is larger, with a market capitalization of $68.01M compared with $67.07M for XBiotech (XBIT).
Which stock has performed better over the past year, HRTX or XBIT?
XBIT returned -18.22% over the past 12 months, compared with -73.47% for HRTX (price return, excluding dividends). Past performance does not predict future results.
Are Heron Therapeutics and XBiotech in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.